Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability

Ítems similars

• Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
  per: Valerie Haller, et al.
  Publicat: (2025-01-01)
• SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
  per: Liangying Zhang, et al.
  Publicat: (2025-02-01)
• cKIT Mutations in GISTs and Other Malignancies in Thailand
  per: Thongbliew Prempree, et al.
  Publicat: (2006-03-01)
• Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
  per: Ebrahimi Keramatollah, et al.
  Publicat: (2019-01-01)
• KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
  per: Shishan Zhou, et al.
  Publicat: (2024-02-01)